IBDEI16J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20830,2)
 ;;=^268227
 ;;^UTILITY(U,$J,358.3,20831,0)
 ;;=305.03^^112^1291^1
 ;;^UTILITY(U,$J,358.3,20831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20831,1,3,0)
 ;;=3^305.03
 ;;^UTILITY(U,$J,358.3,20831,1,4,0)
 ;;=4^Alcohol Abuse,In Remiss
 ;;^UTILITY(U,$J,358.3,20831,2)
 ;;=^268230
 ;;^UTILITY(U,$J,358.3,20832,0)
 ;;=305.90^^112^1291^7
 ;;^UTILITY(U,$J,358.3,20832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20832,1,3,0)
 ;;=3^305.90
 ;;^UTILITY(U,$J,358.3,20832,1,4,0)
 ;;=4^Drug Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,20832,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,20833,0)
 ;;=682.9^^112^1292^2
 ;;^UTILITY(U,$J,358.3,20833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20833,1,3,0)
 ;;=3^682.9
 ;;^UTILITY(U,$J,358.3,20833,1,4,0)
 ;;=4^Cellulitis Unspec
 ;;^UTILITY(U,$J,358.3,20833,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,20834,0)
 ;;=692.9^^112^1292^3
 ;;^UTILITY(U,$J,358.3,20834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20834,1,3,0)
 ;;=3^692.9
 ;;^UTILITY(U,$J,358.3,20834,1,4,0)
 ;;=4^Dermatitis
 ;;^UTILITY(U,$J,358.3,20834,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,20835,0)
 ;;=110.1^^112^1292^4
 ;;^UTILITY(U,$J,358.3,20835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20835,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,20835,1,4,0)
 ;;=4^Dermatophytosis Of Nail
 ;;^UTILITY(U,$J,358.3,20835,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,20836,0)
 ;;=782.1^^112^1292^7
 ;;^UTILITY(U,$J,358.3,20836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20836,1,3,0)
 ;;=3^782.1
 ;;^UTILITY(U,$J,358.3,20836,1,4,0)
 ;;=4^Rash, Nonspecif Skin Eruption
 ;;^UTILITY(U,$J,358.3,20836,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,20837,0)
 ;;=707.10^^112^1292^5
 ;;^UTILITY(U,$J,358.3,20837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20837,1,3,0)
 ;;=3^707.10
 ;;^UTILITY(U,$J,358.3,20837,1,4,0)
 ;;=4^Leg Ulcer, lower limb, chronic
 ;;^UTILITY(U,$J,358.3,20837,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,20838,0)
 ;;=702.0^^112^1292^1
 ;;^UTILITY(U,$J,358.3,20838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20838,1,3,0)
 ;;=3^702.0
 ;;^UTILITY(U,$J,358.3,20838,1,4,0)
 ;;=4^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,20838,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,20839,0)
 ;;=696.1^^112^1292^6
 ;;^UTILITY(U,$J,358.3,20839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20839,1,3,0)
 ;;=3^696.1
 ;;^UTILITY(U,$J,358.3,20839,1,4,0)
 ;;=4^Psoriasis
 ;;^UTILITY(U,$J,358.3,20839,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,20840,0)
 ;;=795.00^^112^1293^2
 ;;^UTILITY(U,$J,358.3,20840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20840,1,3,0)
 ;;=3^795.00
 ;;^UTILITY(U,$J,358.3,20840,1,4,0)
 ;;=4^Abnormal Pap
 ;;^UTILITY(U,$J,358.3,20840,2)
 ;;=^328609
 ;;^UTILITY(U,$J,358.3,20841,0)
 ;;=V25.09^^112^1293^16
 ;;^UTILITY(U,$J,358.3,20841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20841,1,3,0)
 ;;=3^V25.09
 ;;^UTILITY(U,$J,358.3,20841,1,4,0)
 ;;=4^Contraceptive Mgmt (1St Visit)
 ;;^UTILITY(U,$J,358.3,20841,2)
 ;;=^87608
 ;;^UTILITY(U,$J,358.3,20842,0)
 ;;=626.8^^112^1293^17
 ;;^UTILITY(U,$J,358.3,20842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20842,1,3,0)
 ;;=3^626.8
 ;;^UTILITY(U,$J,358.3,20842,1,4,0)
 ;;=4^Dysfunctional Bleeding
 ;;^UTILITY(U,$J,358.3,20842,2)
 ;;=^87521
 ;;^UTILITY(U,$J,358.3,20843,0)
 ;;=628.9^^112^1293^24
 ;;^UTILITY(U,$J,358.3,20843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20843,1,3,0)
 ;;=3^628.9
 ;;^UTILITY(U,$J,358.3,20843,1,4,0)
 ;;=4^Female Infertility NOS
 ;;^UTILITY(U,$J,358.3,20843,2)
 ;;=^62820
 ;;^UTILITY(U,$J,358.3,20844,0)
 ;;=610.1^^112^1293^25
 ;;^UTILITY(U,$J,358.3,20844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20844,1,3,0)
 ;;=3^610.1
 ;;
 ;;$END ROU IBDEI16J
